This article first appeared on GuruFocus .
Release Date: May 14, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
MariMed Inc ( MRMD ) reported first quarter 2026 revenue of $39.5 million and positive adjusted EBITDA of $3.6 million, indicating strong financial performance.
-
The company achieved positive cash flow from operations, showcasing effective operational discipline.
-
Wholesale revenue in Illinois grew by 25% and in Delaware by 13%, strengthening their leadership position in these markets.
-
Betty's Eddies maintained the number one selling edible position across multiple states, demonstrating strong brand presence.
-
The company is expanding its dispensary footprint, with plans to open a new Thrive location in Ohio by the end of the year.
Negative Points
-
Retail revenue declined 7% sequentially, reflecting seasonal trends and market challenges.
-
Gross margin declined by approximately 110 basis points year-over-year, indicating some pressure on profitability.
-
The company faced isolated production issues in Maryland, impacting wholesale sales in that region.
-
Retail sales in Illinois declined 10% year-on-year, primarily due to average order volume pressure.
-
The rescheduling of medical cannabis has not yet led to significant changes in M&A activity or banking relationships, limiting immediate strategic benefits.
Q & A Highlights
Q: John, can you expand on how rescheduling, as it's been announced, changes your strategy? Does it make you more acquisitive or more intent on growing through M&A? A: John Levine, CEO: The rescheduling, along with changes in Massachusetts, has influenced our strategy. We are looking to expand more retail in Massachusetts, which will help us gain additional margins. We are also considering expansion in other states through retail and licensing or purchasing of licenses. The rescheduling and potential adult use in Pennsylvania are expected to positively impact us.
Q: Can you discuss price stabilization in your top markets? Are things beginning to stabilize? A: Ryan Crandall, Chief Commercial Officer: Price stabilization varies by category. In Illinois, prices are still aggressive due to more producers entering the market. Massachusetts shows signs of stabilization but remains competitive. Maryland's wholesale market is challenging due to large producers driving prices down. Delaware has the least compression currently.
Q: In terms of retail, how has revenue per store erosion been in Illinois versus Massachusetts and Maryland? A: Ryan Crandall, Chief Commercial Officer: Revenue per store has seen erosion across markets. We focus on increasing transactions, loyalty programs, and customer engagement to combat this. Despite challenges, well-run businesses that innovate and engage customers will succeed.
Q: What is the percentage of your own brands being sold in your stores, and is there room to increase that? A: Mario Pinha, CFO: Increasing the mix of our own products in our stores is a core strategy. We have dedicated resources to focus on this across all markets, ensuring our products are prioritized and recommended in our stores.
Q: With the rescheduling news, are you receiving more M&A inquiries or offers? A: John Levine, CEO: The rescheduling has not significantly affected M&A inquiries. Banking and credit card companies still operate as if cannabis is illegal. More deals are emerging in Massachusetts due to licensing changes rather than rescheduling.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
